Back to search
FDAFDA · Food and drugs·Recall number D-0820-2023

Levofloxacin Ophthalmic Solution, 0.5%, 5 mL bottles, Rx Only, Manufactured by: Akorn, Inc., Lake Forest, IL 60045. ALL NDCs

Published June 7, 2023 · Recall initiated: April 26, 2023

Summary

FDA records drug Class II recall D-0820-2023, published June 7, 2023 and initiated April 26, 2023. Recalling firm: Akorn, Inc.; Status: Ongoing; Reported quantity: N/A; Lot: All Lots. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

CGMP Deviations: Firm went out of business and could no longer continue stability studies.

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Akorn, Inc.
Distributor
Nationwide in the USA and Puerto Rico
Lot
All Lots
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Levofloxacin Ophthalmic Solution, 0.5%, 5 mL bottles, Rx Only, Manufactured by: Akorn, Inc., Lake Forest, IL 60045. ALL NDCs recalled?

Yes. FDA published recall D-0820-2023 on June 7, 2023. Reported hazard: CGMP Deviations: Firm went out of business and could no longer continue stability studies.

What should I do if I have this product?

Voluntary: Firm initiated · Letter